Serotonin
Based on 35 publication(s) in Google Scholar
Serotonin is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM.
For research use only. We do not sell to patients.
- Purity: 98.96%
- CAS No.: 50-67-9
- Formula: C10H12N2O
- Molecular Weight:176.22
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications Citing Use of MedChemExpress (MCE) Serotonin
More- Nature. 2025 Jul;643(8070):192-200. [Abstract]
- Immunity. 2025 Sep 9;58(9):2320-2335.e9. [Abstract]
- Cell Res. 2026 Apr;36(4):286-299. [Abstract]
- Cell Stem Cell. 2025 Mar 20:S1934-5909(25)00084-0. [Abstract]
- Nat Commun. 2025 Dec 18;16(1):11196. [Abstract]
- J Exp Clin Cancer Res. 2024 Oct 10;43(1):284. [Abstract]
- Small. 2026 Mar;22(14):e11914. [Abstract]
- Cell Rep Med. 2026 Jan 20;7(1):102537. [Abstract]
- J Immunother Cancer. 2021 Jul;9(7):e002383. [Abstract]
- Acta Biomater. 2026 Mar:213:214-232. [Abstract]
- Food Res Int. 2025 Aug:214:116675. [Abstract]
- Curr Res Food Sci. 2024 Apr 26:8:100754. [Abstract]
- Neurosci Bull. 2025 Jul;41(7):1229-1245. [Abstract]
- iScience. 2025 Nov 19;28(12):114120. [Abstract]
- iScience. 2025 Jun 18;28(7):112931. [Abstract]
- J Food Meas Charact. 2026 Jan 30.
- J Dent Sci. 2025 Oct;20(4):2363-2374. [Abstract]
- Fitoterapia. 2026 Apr:190:107182. [Abstract]
- Behav Brain Res. 2025 May 7:115620. [Abstract]
- Biochem Biophys Res Commun. 2025 Sep 19:785:152676. [Abstract]
- Indian J Ophthalmol. 2026 Feb 1;74(2):250-258. [Abstract]
- SSRN. 2026 Jun 16.
- SSRN. 2026 Apr 13.
- bioRxiv. 2026 Mar 19:2026.03.17.712426. [Abstract]
- SSRN. 2026 Mar 6.
- bioRxiv. 2026 Mar 30.
- bioRxiv. 2025 Oct 14.
- bioRxiv. 2025 Sep 28.
- SSRN. 2025 Apr 24.
- bioRxiv. 2024 November 03.
- bioRxiv. 2024 November 03.
- Res Sq. 2024 Jun 11.
- Research Square Preprint. 2023 Dec 28.
- bioRxiv. 2023 Oct 13.
- Authorea. September 19, 2022.
-
Cell Migration/Invasion Assay
-
ELISA
-
Cell Proliferation/Viability Assay
-
RT-PCR
-
WB
All 5-HT Receptor Isoforms
MoreAll Endogenous Metabolite Isoforms
More
Biological Activity
|
Microbial Metabolite |
Human Endogenous Metabolite |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| B16 | IC50 |
>30 μM
Compound: 17
|
Antimelanogenic activity in mouse B16 cells assessed as inhibition of intracellular melanin accumulation after 2 days
Antimelanogenic activity in mouse B16 cells assessed as inhibition of intracellular melanin accumulation after 2 days
|
[PMID: 19524439] |
| B16 | IC50 |
550 μM
Compound: 17
|
Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation
Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation
|
[PMID: 19524439] |
| C6 | EC50 |
12 nM
Compound: 5-HT
|
Agonist activity at human 5HT4 isoform E receptor expressed in rat C6 cells assessed as cAMP accumulation by radio-immunoassay relative to 5HT
Agonist activity at human 5HT4 isoform E receptor expressed in rat C6 cells assessed as cAMP accumulation by radio-immunoassay relative to 5HT
|
[PMID: 19334715] |
| CHO | IC50 |
2.55 x 10-3 μM
Compound: 5-HT
|
Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells
Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells
|
[PMID: 12713409] |
| CHO | EC50 |
3.7 nM
Compound: 5-HT
|
Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor
Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor
|
[PMID: 12954071] |
| CHO | EC50 |
1.5 nM
Compound: 5-HT
|
Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader
Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader
|
[PMID: 15081042] |
| CHO | EC50 |
1.7 nM
Compound: 5-HT
|
Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader
Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader
|
[PMID: 15081042] |
| CHO | EC50 |
11 nM
Compound: 5-HT
|
Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader
Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader
|
[PMID: 15081042] |
| CHO | EC50 |
1.5 nM
Compound: 2
|
Binding to human 5HT2B receptor expressed in CHO cells
Binding to human 5HT2B receptor expressed in CHO cells
|
[PMID: 16257207] |
| CHO | EC50 |
1.7 nM
Compound: 2
|
Binding to human 5HT2C receptor expressed in CHO cells
Binding to human 5HT2C receptor expressed in CHO cells
|
[PMID: 16257207] |
| CHO | EC50 |
11 nM
Compound: 2
|
Binding to human 5HT2A receptor expressed in CHO cells
Binding to human 5HT2A receptor expressed in CHO cells
|
[PMID: 16257207] |
| CHO | EC50 |
1 nM
Compound: 5-HT
|
Agonistic activity at human 5HT1A in CHO cells by the inhibition of forskolin-stimulated cAMP accumulation
Agonistic activity at human 5HT1A in CHO cells by the inhibition of forskolin-stimulated cAMP accumulation
|
[PMID: 16392798] |
| CHO | EC50 |
0.7 nM
Compound: 5-HT
|
Agonist activity assessed by stimulation of [35S]GTP-gamma-S binding to human 5HT1A receptor expressed in CHO cells
Agonist activity assessed by stimulation of [35S]GTP-gamma-S binding to human 5HT1A receptor expressed in CHO cells
|
[PMID: 16458504] |
| CHO | EC50 |
24 nM
Compound: 5-HT
|
Agonist activity at human cloned 5HT2C receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis
Agonist activity at human cloned 5HT2C receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis
|
[PMID: 18035544] |
| CHO | EC50 |
70 nM
Compound: 5-HT
|
Agonist activity at human cloned 5HT2A receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis
Agonist activity at human cloned 5HT2A receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis
|
[PMID: 18035544] |
| CHO | EC50 |
150 nM
Compound: 5-HT
|
Agonist activity at 5HT1A receptor expressed in CHO cells by [35S]GTPgammaS binding assay
Agonist activity at 5HT1A receptor expressed in CHO cells by [35S]GTPgammaS binding assay
|
[PMID: 19559623] |
| CHO | EC50 |
25 nM
Compound: 5-HT
|
Agonist activity at human recombinant 5HT2C receptor expressed in CHO K1 cells assessed as induction of calcium mobilization by FLIPR assay
Agonist activity at human recombinant 5HT2C receptor expressed in CHO K1 cells assessed as induction of calcium mobilization by FLIPR assay
|
[PMID: 19646865] |
| CHO | EC50 |
147 nM
Compound: 5-HT
|
Agonist activity at 5HT1A receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding
Agonist activity at 5HT1A receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding
|
[PMID: 20041669] |
| CHO | EC50 |
1.63 nM
Compound: 5-HT
|
Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assay
Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assay
|
[PMID: 22381048] |
| CHO | IC50 |
1.2 x 10-7 M
Compound: Serotonin
|
Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells
Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells
|
[PMID: 26988801] |
| CHO | IC50 |
2.5 x 10-10 M
Compound: Serotonin
|
Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells
Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells
|
[PMID: 26988801] |
| CHO | IC50 |
1.2 x 10-7 M
Compound: Serotonin
|
Displacement of [3H]LSD from human recombinant 5HT6 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
Displacement of [3H]LSD from human recombinant 5HT6 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
|
[PMID: 27876250] |
| CHO | IC50 |
1.2 x 10-1 μM
Compound: Serotonin
|
Displacement of [3H]LSD from human recombinant 5HT6 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
Displacement of [3H]LSD from human recombinant 5HT6 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
|
[PMID: 27876250] |
| CHO | IC50 |
2.5 x 10-10 M
Compound: Serotonin
|
Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
|
[PMID: 27876250] |
| CHO | EC50 |
4.67 nM
Compound: 1
|
The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist
The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist
|
[PMID: 9871775] |
| CHO-K1 | EC50 |
15 nM
Compound: Serotonin
|
Agonist activity at human recombinant 5HT7 receptor expressed in CHOK1 cells assessed as increase in cAMP levels by HTRF assay
Agonist activity at human recombinant 5HT7 receptor expressed in CHOK1 cells assessed as increase in cAMP levels by HTRF assay
|
[PMID: 19326916] |
| CHO-K1 | EC50 |
16 nM
Compound: 5-HT
|
Agonist activity at 5HT2A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay
Agonist activity at 5HT2A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay
|
[PMID: 23675993] |
| CHO-K1 | EC50 |
39 nM
Compound: 5-HT
|
Agonist activity at 5HT1A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay
Agonist activity at 5HT1A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay
|
[PMID: 23675993] |
| CHO-K1 | EC50 |
15.33 nM
Compound: 5-HT
|
Agonist activity at 5-HT1A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay
Agonist activity at 5-HT1A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay
|
[PMID: 27487565] |
| CHO-K1 | EC50 |
47 nM
Compound: 5-HT
|
Agonist activity at 5-HT2A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay
Agonist activity at 5-HT2A receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by Fluo-4 dye based FLIPR assay
|
[PMID: 27487565] |
| CHO-K1 | EC50 |
18 nM
Compound: Serotonin
|
Agonist activity at human recombinant 5HT1A receptor (unknown origin) stably expressed in CHO-K1 incubated for 30 mins by [35S]GTPgammaS binding assay
Agonist activity at human recombinant 5HT1A receptor (unknown origin) stably expressed in CHO-K1 incubated for 30 mins by [35S]GTPgammaS binding assay
|
[PMID: 31627993] |
| CHO-K1 | EC50 |
45.3 nM
Compound: Serotonin
|
Partial agonist activity at recombinant human 5-HT1A expressed in CHO-K1 cells by pathhunter beta-arrestin assay
Partial agonist activity at recombinant human 5-HT1A expressed in CHO-K1 cells by pathhunter beta-arrestin assay
|
[PMID: 32631554] |
| CHO-K1 | EC50 |
0.07 μM
Compound: Serotonin
|
Agonist activity at human recombinant 5-HT7 receptor expressed in CHOK1 Hunter cell incubated for 30 to 60 mins by hit-hunter cAMP assay based chemiluminescence analysis
Agonist activity at human recombinant 5-HT7 receptor expressed in CHOK1 Hunter cell incubated for 30 to 60 mins by hit-hunter cAMP assay based chemiluminescence analysis
|
[PMID: 32631561] |
| CHO-K1 | EC50 |
4.82 nM
Compound: 5-HT
|
Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells
Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells
|
[PMID: 8960551] |
| Flp-In-293 | EC50 |
0.19 nM
Compound: Serotonin
|
Agonist activity at recombinant human unedited 5HT2C receptor isoform INI expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
Agonist activity at recombinant human unedited 5HT2C receptor isoform INI expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
|
[PMID: 31445232] |
| Flp-In-293 | EC50 |
0.27 nM
Compound: Serotonin
|
Agonist activity at recombinant human 5HT2A receptor expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
Agonist activity at recombinant human 5HT2A receptor expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
|
[PMID: 31445232] |
| Flp-In-293 | EC50 |
0.86 nM
Compound: Serotonin
|
Agonist activity at recombinant human 5HT2B receptor expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
Agonist activity at recombinant human 5HT2B receptor expressed in Flp-In-293 cells assessed as increase in calcium influx measured for 300 secs by Fluo-4 dye based FLIPR assay
|
[PMID: 31445232] |
| HEK293 | EC50 |
0.5 μM
Compound: 5-HT
|
Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay
Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay
|
[PMID: 17722904] |
| HEK293 | EC50 |
0.1 μM
Compound: serotonin
|
Activity at SER4 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay
Activity at SER4 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay
|
[PMID: 18033297] |
| HEK293 | EC50 |
0.09 nM
Compound: 1
|
Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
|
[PMID: 19284718] |
| HEK293 | EC50 |
0.5 nM
Compound: 1
|
Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
|
[PMID: 19284718] |
| HEK293 | EC50 |
5.8 nM
Compound: 1
|
Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
|
[PMID: 19284718] |
| HEK293 | EC50 |
141 nM
Compound: 5-HT
|
Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release
Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release
|
[PMID: 21146988] |
| HEK293 | EC50 |
178 nM
Compound: 5-HT
|
Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response
Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response
|
[PMID: 21146988] |
| HEK293 | EC50 |
0.09 nM
Compound: 5-HT
|
Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
|
[PMID: 22778800] |
| HEK293 | EC50 |
0.86 nM
Compound: 5-HT
|
Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
|
[PMID: 22778800] |
| HEK293 | EC50 |
7.6 nM
Compound: 5-HT
|
Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay
|
[PMID: 22778800] |
| HEK293 | EC50 |
0.0026 μM
Compound: 5-HT, serotonin
|
Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay
Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay
|
[PMID: 23301527] |
| HEK293 | EC50 |
0.044 μM
Compound: 5-HT, serotonin
|
Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay
Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay
|
[PMID: 23301527] |
| HEK293 | EC50 |
0.15 μM
Compound: 5-HT, serotonin
|
Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay
Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay
|
[PMID: 23301527] |
| HEK293 | EC50 |
0.00087 μM
Compound: 5-HT, serotonin
|
Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay
Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay
|
[PMID: 23301527] |
| HEK293 | EC50 |
0.87 nM
Compound: 5-HT, serotonin
|
Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay
Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay
|
[PMID: 23301527] |
| HEK293 | EC50 |
3.75 nM
Compound: 5-HT
|
Agonist activity at 5-HT1A receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay
Agonist activity at 5-HT1A receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay
|
[PMID: 23332346] |
| HEK293 | EC50 |
0.4 nM
Compound: 5-HT
|
Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
|
[PMID: 23602445] |
| HEK293 | EC50 |
1.1 nM
Compound: 5-HT
|
Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
|
[PMID: 23602445] |
| HEK293 | EC50 |
1.5 nM
Compound: 5-HT
|
Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay
|
[PMID: 23602445] |
| HEK293 | EC50 |
0.017 μM
Compound: 5-HT, serotonin
|
Agonist activity at human 5-HT7 expressed in HEK-293 cells assessed as increase in cAMP level after 45 mins by HTRF assay
Agonist activity at human 5-HT7 expressed in HEK-293 cells assessed as increase in cAMP level after 45 mins by HTRF assay
|
[PMID: 25073094] |
| HEK293 | EC50 |
0.21 nM
Compound: 5-HT
|
Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
|
[PMID: 25633969] |
| HEK293 | EC50 |
0.92 nM
Compound: 5-HT
|
Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
|
[PMID: 25633969] |
| HEK293 | EC50 |
1.88 nM
Compound: 5-HT
|
Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay
|
[PMID: 25633969] |
| HEK293 | IC50 |
1.8 x 10-7 M
Compound: Serotonin
|
Displacement of [3H]LSD from human recombinant 5-HT5A receptor expressed in HEK293 cells
Displacement of [3H]LSD from human recombinant 5-HT5A receptor expressed in HEK293 cells
|
[PMID: 26988801] |
| HEK293 | EC50 |
5.8 nM
Compound: 5-HT
|
Agonist activity at human 5-HT7R expressed in HEK293 cells assessed as induction of cAMP levels treated for 10 mins measured after 30 mins by D2-dye based fluorescence assay
Agonist activity at human 5-HT7R expressed in HEK293 cells assessed as induction of cAMP levels treated for 10 mins measured after 30 mins by D2-dye based fluorescence assay
|
[PMID: 27475109] |
| HEK293 | EC50 |
5.8 x 10-3 μM
Compound: 5-HT
|
Agonist activity at human 5-HT7R expressed in HEK293 cells assessed as induction of cAMP levels treated for 10 mins measured after 30 mins by D2-dye based fluorescence assay
Agonist activity at human 5-HT7R expressed in HEK293 cells assessed as induction of cAMP levels treated for 10 mins measured after 30 mins by D2-dye based fluorescence assay
|
[PMID: 27475109] |
| HEK293 | IC50 |
1.8 x 10-7 M
Compound: Serotonin
|
Displacement of [3H]LSD from human recombinant 5HT5A receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method
Displacement of [3H]LSD from human recombinant 5HT5A receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method
|
[PMID: 27876250] |
| HEK293 | IC50 |
1.8 x 10-1 μM
Compound: Serotonin
|
Displacement of [3H]LSD from human recombinant 5HT5A receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method
Displacement of [3H]LSD from human recombinant 5HT5A receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method
|
[PMID: 27876250] |
| HEK293 | IC50 |
260 nM
Compound: Serotonin
|
Displacement of [3H]LSD from human recombinant 5-HT5a receptor in HEK293 cells after 120 mins by scintillation counting
Displacement of [3H]LSD from human recombinant 5-HT5a receptor in HEK293 cells after 120 mins by scintillation counting
|
[PMID: 27997171] |
| HEK293 | EC50 |
0.17 nM
Compound: 5-HT
|
Agonist activity at human 5-HT2C-INI receptor isoform expressed in Flp-IN HEK293 cells assessed as induction of Gq-mediated calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
Agonist activity at human 5-HT2C-INI receptor isoform expressed in Flp-IN HEK293 cells assessed as induction of Gq-mediated calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
|
[PMID: 28657744] |
| HEK293 | EC50 |
1.46 nM
Compound: 5-HT
|
Agonist activity at human 5-HT2B receptor expressed in Flp-IN HEK293 cells assessed as induction of calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
Agonist activity at human 5-HT2B receptor expressed in Flp-IN HEK293 cells assessed as induction of calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
|
[PMID: 28657744] |
| HEK293 | EC50 |
2.35 nM
Compound: 5-HT
|
Agonist activity at human 5-HT2A receptor expressed in Flp-IN HEK293 cells assessed as induction of calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
Agonist activity at human 5-HT2A receptor expressed in Flp-IN HEK293 cells assessed as induction of calcium flux measured every second for 5 mins by Fluo-4 dye based FLIPR assay
|
[PMID: 28657744] |
| HEK293 | EC50 |
0.41 nM
Compound: 5-HT
|
Agonist activity at human 5HT2C receptor stably expressed in HEK293 cells co-expressing Gq assessed as induction of calcium mobilization measured at 1 sec interval for 60 secs by Fluo-4 calcium dye based FLIPR assay
Agonist activity at human 5HT2C receptor stably expressed in HEK293 cells co-expressing Gq assessed as induction of calcium mobilization measured at 1 sec interval for 60 secs by Fluo-4 calcium dye based FLIPR assay
|
[PMID: 32282200] |
| HEK293-EBNA | EC50 |
5.8 nM
Compound: 5-HT
|
Agonist activity at human cloned 5HT2B receptor expressed in HEK293-EBNA cells assessed as myo-[3H]inositol hydrolysis
Agonist activity at human cloned 5HT2B receptor expressed in HEK293-EBNA cells assessed as myo-[3H]inositol hydrolysis
|
[PMID: 18035544] |
| HRPE | IC50 |
97 μM
Compound: Serotonin
|
TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells
TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells
|
[PMID: 9830022] |
| NG108-15 | EC50 |
298 nM
Compound: 5-HT
|
Quantitative effect on the [14C]guanidinium accumulation in NG 108-15 cells.
Quantitative effect on the [14C]guanidinium accumulation in NG 108-15 cells.
|
[PMID: 10229626] |
| NG108-15 | EC50 |
293 nM
Compound: 5-HT
|
In Vitro 5-HT3 agonist activity on the [14C]guanidinium accumulation in NG 108-15 cells.
In Vitro 5-HT3 agonist activity on the [14C]guanidinium accumulation in NG 108-15 cells.
|
[PMID: 9191957] |
| Oocyte | EC50 |
12 μM
Compound: Serotonin
|
Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes
Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes
|
[PMID: 15050614] |
| U2OS | IC50 |
1.25 nM
Compound: Serotonin
|
Antagonist activity at recombinant human 5-HT2C expressed in human U2OS cells by pathhunter beta-arrestin assay
Antagonist activity at recombinant human 5-HT2C expressed in human U2OS cells by pathhunter beta-arrestin assay
|
[PMID: 32631554] |
| U2OS | IC50 |
27.9 nM
Compound: Serotonin
|
Antagonist activity at recombinant human 5-HT2A expressed in human U2OS cells by pathhunter beta-arrestin assay
Antagonist activity at recombinant human 5-HT2A expressed in human U2OS cells by pathhunter beta-arrestin assay
|
[PMID: 32631554] |
Serotonin is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin also inhibits catechol O-methyltransferase (COMT), an enzyme that contributes to modultion the perception of pain, via non-competitive binding to the site bound by catechol substrates with a binding affinity comparable to the binding affinity of catechol itself (Ki= 44 μM). Results show that addition of 100 μM of Serotonin decreases the reaction velocity of COMT[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 50-67-9
-
Appearance Solid
-
Molecular Weight 176.22
-
Formula C10H12N2O
-
Color Light yellow to brown
-
SMILES
OC1=CC2=C(NC=C2CCN)C=C1
-
Synonyms
5-Hydroxytryptamine; 5-HT
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (35)
-
Journal Impact Factor
-
Most Recent
-
Nature
2025 Jul;643(8070):192-200. PMID: 39695227 -
Immunity
Spatiotemporal dynamics of CXCL10 encode contextual immune information revealed by the genetically encoded fluorescent sensor. [Abstract]2025 Sep 9;58(9):2320-2335.e9. PMID: 40818452 -
Cell Res
Light sensing enhances thermotolerance and competitive fitness via serotonergic signaling in an eyeless organism. [Abstract]2026 Apr;36(4):286-299. PMID: 41764323 -
Cell Stem Cell
Vagal pathway activation links chronic stress to decline in intestinal stem cell function. [Abstract]2025 Mar 20:S1934-5909(25)00084-0. PMID: 40120585 -
Nat Commun
2025 Dec 18;16(1):11196. PMID: 41413037 -
J Exp Clin Cancer Res
Mechanisms of neural infiltration-mediated tumor metabolic reprogramming impacting immunotherapy efficacy in non-small cell lung cancer. [Abstract]2024 Oct 10;43(1):284. PMID: 39385213 -
Small
Acupuncture Mechanics, Stimulation, and Cellular Serotonin Detection by a Magneto-Responsive Nanomesh Sensor. [Abstract]2026 Mar;22(14):e11914. PMID: 41537659 -
Cell Rep Med
5-HT reuptake blockade induces pyroptosis in BRAFV600E-mutated melanomas via remodeling histone serotonylation. [Abstract]2026 Jan 20;7(1):102537. PMID: 41494533 -
J Immunother Cancer
GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer. [Abstract]2021 Jul;9(7):e002383. PMID: 34281987
Serotonin purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2021 Jul;9(7):e002383. [Abstract]
Relative IDO1 transcription levels detected by quantitative reverse transcription PCR (qRT-PCR) analysis in BT549 cells treated with dimethyl sulfoxide (DMSO), tetrahydrobiopterin (BH4, 10 µM), 5-HTP (500 µM), serotonin (10 µM), NAS (100 µM), and melatonin (1 µM) for 24 hours.
Serotonin purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2021 Jul;9(7):e002383. [Abstract]
Relative IDO1 levels detected by western blot in BT549 cells treated with dimethyl sulfoxide (DMSO), tetrahydrobiopterin (BH4, 10 µM), 5-HTP (500 µM), serotonin (10 µM), NAS (100 µM), and melatonin (1 µM) for 24 hours.
-
Acta Biomater
Sequential dual-drug delivery biomimetic hydrogel for temporal orchestration of acute neuroprotection and chronic regeneration in spinal cord injury. [Abstract]2026 Mar:213:214-232. PMID: 41654155 -
Food Res Int
Polysaccharide from Aloe vera gel improves intestinal stem cells dysfunction to alleviate intestinal barrier damage via 5-HT. [Abstract]2025 Aug:214:116675. PMID: 40467243 -
Curr Res Food Sci
2024 Apr 26:8:100754. PMID: 38736909
Serotonin purchased from MedChemExpress. Usage Cited in: Curr Res Food Sci. 2024 Apr 26:8:100754. [Abstract]
Dose-response and time course of cell viability after in vitro administration of 5-HT(Serotonin);
-
Neurosci Bull
Targeting 5-HT to Alleviate Dose-Limiting Neurotoxicity in Nab-Paclitaxel-Based Chemotherapy. [Abstract]2025 Jul;41(7):1229-1245. PMID: 40369268 -
iScience
2025 Nov 19;28(12):114120. PMID: 41438086
Serotonin purchased from MedChemExpress. Usage Cited in: iScience. 2025 Nov 19;28(12):114120. [Abstract]
Scratch tests were used to observe the migration ability of MLE-12 cells treated with 5-HT (Serotonin, 10 μM) for 24 h.
-
iScience
Deficiency of Rab26 causes behavioral defects in mice through impaired trafficking of serotonin (5-HT) transporter. [Abstract]2025 Jun 18;28(7):112931. PMID: 40687824
Serotonin purchased from MedChemExpress. Usage Cited in: iScience. 2025 Jun 18;28(7):112931. [Abstract]
SH-SY5Y cells were treated with 10 μM Serotonin (5-HT), then the intracellular 5-HT was detected through ELISA assay for 0, 60, 120 min.
-
-
J Dent Sci
Serotonin promotes lip sensory recovery after inferior alveolar nerve transection via histone serotonylation. [Abstract]2025 Oct;20(4):2363-2374. PMID: 41040553 -
Fitoterapia
The stem-derived bioactive fraction of Syringa oblata Lindl. Ameliorates insomnia via cAMP signaling-mediated regulation of neurotransmission, oxidative stress, and inflammation: A multi-omics study. [Abstract]2026 Apr:190:107182. PMID: 41861857 -
Behav Brain Res
Serotonin mitigates depression in a rotenone-induced mouse Parkinson's disease model by inhibiting hippocampal neuronal pyroptosis and neuroinflammation. [Abstract]2025 May 7:115620. PMID: 40345554 -
Biochem Biophys Res Commun
Glucose transports in the ileum: mechanism, regulation and physiological role of ileal glucose absorption. [Abstract]2025 Sep 19:785:152676. PMID: 41005286 -
Indian J Ophthalmol
Ranitidine protects Müller cells against ferroptosis in diabetic retinopathy by regulating the AKT1/GSK3β pathway. [Abstract]2026 Feb 1;74(2):250-258. PMID: 41581041 -
-
-
bioRxiv
2026 Mar 19:2026.03.17.712426. PMID: 41890023 -
-
-
-
-
-
-
-
-
-
-
Solvent & Solubility
DMSO : 100 mg/mL (567.47 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (14.19 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (14.19 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocol
For macrophage culture, peritoneal cavity cells are collected from WT and IL-13-/- mice with or without dextran sodium sulfate (DSS) treatment and cultured. Cells are plated at a concentration of 3.0×106 cells per millilitre, and treated with either lipopolysaccharides (LPS); (100 ng/mL) or Serotonin (10-10 M) for 24 hours. The culture supernatant are collected and stored in -80°C until determination of cytokine levels using protein array system[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Dextran sodium sulfate (DSS) colitis is induced by orally administering 5% DSS in drinking water for 5 days. In a separate experiment, IL-13-/- mice are injected subcutaneously with 100 mg/kg of Serotonin (5-HTP) twice daily for 8 days beginning 3 days prior to induction of DSS colitis; whereas, the control IL-13-/- mice receive saline as vehicle. Animals are anaesthetized prior to euthanization via cervical dislocation at the conclusion of each experiment or if they reach a predetermined end point (ie, loss of ≥20% body weight and/or significant deterioration of body condition)[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (420 KB)
- English - EN (420 KB)
- Français - FR (420 KB)
- Deutsch - DE (420 KB)
- Norwegian - NO (420 KB)
- Español - ES (420 KB)
- Swedish - SV (420 KB)
- Italian - IT (420 KB)
- Korean - KR (420 KB)
- Portuguese - PT (420 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 5.6747 mL | 28.3736 mL | 56.7472 mL | 141.8681 mL |
| 5 mM | 1.1349 mL | 5.6747 mL | 11.3494 mL | 28.3736 mL | |
| 10 mM | 0.5675 mL | 2.8374 mL | 5.6747 mL | 14.1868 mL | |
| 15 mM | 0.3783 mL | 1.8916 mL | 3.7831 mL | 9.4579 mL | |
| 20 mM | 0.2837 mL | 1.4187 mL | 2.8374 mL | 7.0934 mL | |
| 25 mM | 0.2270 mL | 1.1349 mL | 2.2699 mL | 5.6747 mL | |
| 30 mM | 0.1892 mL | 0.9458 mL | 1.8916 mL | 4.7289 mL | |
| 40 mM | 0.1419 mL | 0.7093 mL | 1.4187 mL | 3.5467 mL | |
| 50 mM | 0.1135 mL | 0.5675 mL | 1.1349 mL | 2.8374 mL | |
| 60 mM | 0.0946 mL | 0.4729 mL | 0.9458 mL | 2.3645 mL | |
| 80 mM | 0.0709 mL | 0.3547 mL | 0.7093 mL | 1.7734 mL | |
| 100 mM | 0.0567 mL | 0.2837 mL | 0.5675 mL | 1.4187 mL |